Hormone Optimization: Improve Your Thyroid Health Today

Unlock the secrets of thyroid health with hormone optimization and improve your energy, mood, and metabolism.

Educational Abstract: Integrative Thyroid Care, Conversion Physiology, and Evidence-Based Strategies

In this educational post, I guide you through a clear, first-person journey into the nuances of thyroid physiology, lab interpretation, and modern integrative care. I explain why many people can be fully symptomatic for hypothyroidism despite “normal” thyroid-stimulating hormone (TSH) and T4 values—often because of low free T3 and impaired conversion from T4 to T3. I detail the roles of enzymes such as deiodinase-1, how stress, restrictive dieting, aging, and certain medications can depress T3, and why optimizing free T3 is essential for mood, metabolism, cardiovascular resilience, and gut health. I also show how our integrative team in El Paso, Texas, blends chiropractic care, internal medicine oversight, functional medicine, rehabilitation, and personal injury support, under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), to deliver evidence-based, patient-centered thyroid strategies. This comprehensive guide concludes with practical protocols, the physiologic reasoning behind each step, and insights from leading research, all framed by clinical observations from my practice.

Understanding Thyroid Symptoms Beyond TSH: Why Free T3 Matters

I have seen this scenario countless times: a patient has a “normal” TSH and free T4, yet remains clearly symptomatic—cold hands and feet, thinning hair or eyebrows, dry skin, constipation, depression, anxiety, brain fog, palpitations, and trouble losing or keeping off weight. The missing piece is often free T3, the biologically active thyroid hormone that binds nuclear thyroid hormone receptors and drives metabolic rate, mitochondrial biogenesis, neurotransmitter balance, lipid processing, and gut motility (Jonklaas et al., 2014; Mullur et al., 2014).

Here’s the physiological crux:

• TSH is a pituitary hormone that responds primarily to circulating T4 levels, not to T3.
• The thyroid gland secretes about 80% T4 and ~20% T3. Most intracellular T3 is derived from the peripheral conversion of T4 to T3 by deiodinase enzymes (D1 and D2).
• You can have normal T4 and TSH, but low free T3 due to impaired conversion, and feel hypothyroid in everyday life.

This is why we test a full panel—TSH, free T4, and free T3—and why we interpret the numbers through a functional lens rooted in current evidence and patient outcomes (Jonklaas et al., 2014).

Thyroid Physiology 101: The TSH–T4 Axis and the T3 Conversion Step

To make the thyroid story simple and actionable, I walk patients through the feedback loop:

• Low T4 → higher TSH. The pituitary signals the thyroid to produce more T4 when circulating T4 levels fall.
• High T4 → lower TSH. The pituitary eases off when T4 rises.
• T3 is the “doer.” Free T3 binds thyroid hormone receptors (TRα/TRβ) in target tissues to regulate gene transcription affecting metabolism, cardiac output, thermogenesis, mood, GI motility, hair/skin matrix turnover, and lipid handling (Mullur et al., 2014).

The crucial step is conversion. The D1/D2 deiodinases convert T4 to T3; D3 shunts T4/T3 to inactive reverse T3 (rT3), especially during stress or illness (Peeters et al., 2005). When deiodinase-1 activity is compromised, you can be biochemically “normal” by TSH, yet physiologically hypothyroid at the tissue level.

The Problem With “Normal” Reference Ranges and Why Optimal Matters

I educate patients about lab reference ranges as population averages, not ideal health targets. Many ranges reflect mixed cohorts, including chronically ill individuals. Sitting at the low end of “normal” is often associated with increased risk:

• Lower thyroid hormone activity correlates with higher all-cause mortality, cardiovascular disease, and inflammatory burden in several observational analyses and physiologic models (Razvi et al., 2008; Biondi & Cooper, 2008).
• Vitamin D is a helpful analogy: reference ranges often cite 30–100 ng/mL, yet risk reduction for cancer and cardiovascular disease consistently improves above ~50–60 ng/mL (Garland et al., 2014; Scragg et al., 2018). We apply similar optimal-target thinking to thyroid.

Practical takeaway: we aim to move symptomatic patients into the upper third of the free T3 reference range, where clinical outcomes and lived experiences improve. In my clinical observations, many adults feel best with free T3 around 4.0–5.0 pg/mL, provided heart rate, blood pressure, and symptom tracking remain favorable.

The Physiology of Low T3 Syndrome: Stress, Dieting, Medications, and Aging

The most common pattern I encounter is low free T3 with normal TSH/free T4. Multiple mechanisms converge:

• Stress and HPA-axis activation: Elevated cortisol levels downregulate D1/D2 receptors and upregulate D3 receptors, promoting reverse T3 and blunting T3 availability (Peeters et al., 2005). Clinically, this presents as fatigue, cold intolerance, insomnia, and mood shifts.
• Restrictive calorie intake and rapid weight loss: An energy deficit signals the body to conserve energy; deiodinase activity falls, T3 drops, and metabolic rate declines. In patients using GLP-1 agonists (e.g., semaglutide, tirzepatide), I observe notable suppression of free T3 when appetite falls dramatically. These agents help insulin resistance and weight control, but we must support thyroid physiology to avoid metabolic “overshoot.”
• Aging: With age, tissue responsiveness to T3 may fall; receptor co-factor dynamics and inflammation reduce effective signaling (Mullur et al., 2014).
• Medications: Some patients on T4-only therapy have excellent TSH yet persistent symptoms, likely due to suppressed D1 or insufficient peripheral conversion (Jonklaas et al., 2014). Beta-blockers, steroids, amiodarone, and some psychotropics can also impact conversion.
• Insulin resistance and inflammatory states: These reduce D1/D2 expression and impair cellular uptake and receptor function, producing the clinical phenotype of non-thyroidal illness syndrome or low T3 syndrome (Fliers et al., 2015).

Why this matters: free T3 drives mitochondrial throughput, thermogenesis, cardiac chronotropy/inotropy, and peristalsis. Low T3 through any of these mechanisms propagates a cascade—from dry skin and slow gut transit to depressed mood and exercise intolerance—that patients feel in daily life.

Integrative Team-Based Care in El Paso: MD Oversight, Chiropractic Integration, Functional Medicine, and Rehabilitation

Our clinic—Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas—uses a multidisciplinary approach to improve outcomes for complex cases. We are guided by Medical Director and Collaborative Physician Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who brings over 40 years of experience in internal medicine. This structure is common in integrative and injury care clinics, pairing an MD for medical direction with a chiropractor for biomechanical and functional care.

As Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I provide integrative chiropractic care, functional medicine analysis, and rehabilitation planning. Together, we:

• Coordinate testing: TSH, free T4, free T3, and targeted labs for inflammation (CRP), insulin resistance (fasting insulin/HOMA-IR), micronutrients (selenium, zinc), vitamin D, and gut markers as indicated.
• Align treatment priorities: When free T3 is low, we co-manage stress reduction, nutrition, sleep restoration, and, when appropriate, compounded T3/T4 or desiccated thyroid under MD oversight.
• Integrate injury care: Pain and post-trauma stress suppress thyroid conversion. Chiropractic adjustments, soft-tissue work, and structured rehab reduce nociceptive input and HPA-axis activation, allowing thyroid conversion to recover.
• Apply functional medicine: We map root causes, including sleep debt, dietary deficits, gut dysbiosis, micronutrient insufficiency, and medication interactions (IFM, 2024). Then we correct these through precise, measured protocols.
• Monitor outcomes: Regular vitals, symptom scales, and lab re-checks ensure we move into a free T3 sweet spot while safeguarding cardiovascular and neuropsychiatric stability.

This integrated oversight prevents siloed care and ensures that thyroid strategies are synchronized with musculoskeletal rehabilitation, metabolic goals, and overall safety.

Clinical Observations: Patterns I See and How We Adapt Care

From my daily practice and shared insights on WellnessDoctorRX and LinkedIn, these consistent patterns guide our protocols:

• Patients on GLP-1 therapy who lose appetite rapidly often report cold intolerance, hair thinning, and low mood within 6–10 weeks. Free T3 typically trends down. We stabilize intake (adequate protein, omega-3 fats), titrate fasting windows, and use gentle refeeding to restore conversion.
• Individuals with high stress load improve free T3 with stress management: breath training, HRV-guided parasympathetic work, and cognitive strategies. Adjustment and soft-tissue therapy reduce pain and autonomic arousal.
• Those on T4-only therapy with persistent symptoms often benefit from combination T4/T3 therapy or desiccated thyroid (when appropriate), aiming for the upper-normal free T3 range. We do this carefully, especially if palpitations are present, under Dr. Cardenas’ medical supervision.
• Gut dysbiosis (constipation, bloating, IBS) correlates with low T3 symptoms. Optimizing thyroid often improves motility, while gut repair decreases inflammation and may enhance receptor responsiveness.

These observations reflect how physiology plays out in real humans—confirming the literature while reminding us that context and careful titration matter.

Evidence-Based Lab Strategy: What to Test and Why

We take a structured approach to thyroid assessment:

• Core thyroid panel:

• • TSH: Screens the axis but misses conversion issues.
  • Free T4: Supplies substrate for conversion.
  • Free T3: Reflects active hormone available to tissues.

• Contextual markers:

• • Reverse T3 (rT3): Optional when stress or illness is suspected; elevated rT3 suggests D3 pathway prominence (Peeters et al., 2005).
  • CRP/ESR: Inflammation impacts receptor signaling.
  • Fasting insulin/HOMA-IR: Insulin resistance correlates with lower deiodinase activity (Fliers et al., 2015).
  • Vitamin D, selenium, zinc, iron status: Co-factors for thyroid hormone synthesis and conversion; deficiencies impair T3 generation (Zimmermann, 2011).
  • Lipid panel: Hypothyroidism elevates LDL/triglycerides; improved T3 often normalizes dyslipidemia (Duntas, 2002).

We interpret results using symptom context, vitals, and risk profiles, avoiding a purely numerical approach. The goal is metabolic resilience, psychological clarity, and gut rhythm—not “normal” paper values alone.

Why Integrative Chiropractic Care Helps Thyroid Patients

Patients often ask how chiropractic fits thyroid care. The answer is neurophysiology and stress modulation:

• Autonomic balance: Persistent pain and joint dysfunction elevate sympathetic tone. Spinal adjustments and soft-tissue mobilization improve afferent signaling, reduce nociceptive drive, and help rebalance the autonomic nervous system—lowering stress hormones that suppress D1/D2.
• Movement as a metabolic signal: Guided rehabilitation increases mitochondrial demand and improves insulin sensitivity, which supports T3 utilization and receptor responsiveness.
• Breath and posture mechanics: Diaphragmatic function influences vagal tone. Correcting rib and thoracic mobility enhances parasympathetic activity, improving sleep and gut motility—both vital for the effectiveness of thyroid hormone.

In our clinic, chiropractic is not a standalone solution; it’s a powerful lever within an MD-directed integrative framework that restores the conditions under which thyroid physiology thrives.

Treatment Rationale: Stepwise Protocols and The “Why” Behind Each Step

We tailor protocols to each patient, but the logic remains consistent:

• Reduce physiologic friction

• • Stress modulation (breathwork, mindfulness, HRV biofeedback) lowers cortisol and D3 levels, thereby normalizing conversion to T3 (Peeters et al., 2005).
  • Sleep optimization restores circadian alignment, supporting thyroid axis stability (Kalsbeek et al., 2012).

• Nutritional repletion

• • Adequate protein and healthy fats support hormone transport and receptor integrity.
  • Selenium supports deiodinase function; zinc supports thyroid hormone synthesis; iron supports thyroid peroxidase activity (Zimmermann, 2011).
  • Vitamin D promotes immune balance and may influence mood and metabolic endpoints relevant to thyroid function (Scragg et al., 2018).

• Metabolic calibration

• • Moderate, sustainable caloric intake avoids starvation signals that lower T3.
  • Exercise dosing (resistance plus aerobic) improves insulin sensitivity and receptor utilization.

• Medication precision (when indicated)

• • If free T3 remains suboptimal despite foundational work—and symptoms persist—we collaborate on combination T4/T3 or desiccated thyroid. This raises free T3 into the optimal range without overshooting into hyperthyroidism. Continuous monitoring—resting heart rate, blood pressure, sleep quality, anxiety scale, and repeat labs—guides dosing.

• Chiropractic and rehabilitation

• • Adjustments and soft tissue therapy reduce pain and HPA-axis strain.
  • Progressive rehab supports mitochondrial and metabolic capacity, congruent with rising T3.

Each step reduces barriers to conversion and receptor signaling, making thyroid hormones more effective in real life—not just on a lab sheet.

Common Myths Debunked: Thyroid Medication and Permanence

A frequent concern is: “If I start thyroid medication, am I on it forever?” The answer depends on the root cause:

• Primary hypothyroidism (high TSH, low T4): often requires lifelong therapy; the gland underproduces hormone.
• Conversion-related low T3 in a normal TSH/T4 context: not necessarily permanent. If stress, diet, sleep, or metabolic issues are corrected, some patients can reduce or discontinue combination therapy under supervision. The pituitary-thyroid axis uses feedback loops; stopping medication lets TSH rise as needed to stimulate endogenous production.

We approach medication as part of a therapeutic arc, not a sentence—always personalized, always monitored.

---

THYROID DYSFUNCTION ***MUST WATCH*** (Assessment and treatment)- Video

---

Practical Checklist: Steps You Can Take Now

• Discuss a full thyroid panel with your clinician: TSH, free T4, free T3, and consider rT3 if stress/illness is prominent.
• Track symptoms: cold intolerance, skin/hair changes, constipation, mood, sleep, heart rate.
• Stabilize nutrition: adequate protein (1.2–1.6 g/kg/day), omega-3 fats, and micronutrients (selenium, zinc, iron, vitamin D).
• Review medications that may affect conversion; plan adjustments with your physician.
• Commit to stress practices: 5–10 minutes of box breathing or HRV-guided breath; brief daily mindfulness.
• Move consistently: resistance training 2–3 days/week, aerobic 150 minutes/week; scale to your capacity.
• Consider integrative care: combine chiropractic for autonomic balance with medical oversight to calibrate labs and medications.

Our Multidisciplinary Promise in El Paso

Under the medical leadership of Dr. Maria Guadalupe Cardenas, MD, and within an integrative chiropractic-functional medicine model, we ensure that thyroid care is holistic, evidence-based, and personalized. We coordinate testing, optimize conversion, modulate stress, and—when needed—use targeted thyroid medications. Our aim is simple: translate physiology into feeling better.

If your labs say “normal” but your life says otherwise, let’s look deeper—together.

References

• Biondi, B., & Cooper, D. S. (2008). The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews, 29(1), 76–131.
• Duntas, L. H. (2002). Thyroid disease and lipids. Thyroid, 12(4), 287–293.
• Fliers, E., Klieverik, L. P., & Kalsbeek, A. (2015). Thyroid hormone and energy metabolism. Physiology, 25(3), 218–228.
• Garland, C. F., Kim, J. J., Mohr, S. B., & Garland, F. C. (2014). Meta-analysis of Vitamin D, serum 25(OH)D, and cancer. Dermato-Endocrinology, 1(2), 73–80.
• Institute for Functional Medicine. (2024). Functional medicine approach to endocrine and metabolic health.
• Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., et al. (2014). Guidelines for the treatment of hypothyroidism. Thyroid, 24(12), 1670–1751.
• Kalsbeek, A., et al. (2012). The circadian clock and endocrine homeostasis. Endocrine Reviews, 33(1), 1–41.
• Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014). Thyroid hormone regulation of metabolism. Physiological Reviews, 94(2), 355–382.
• Peeters, R. P., et al. (2005). Tissue thyroid hormone levels in critical illness. Journal of Clinical Endocrinology & Metabolism, 90(12), 6498–6503.
• Razvi, S., et al. (2008). Subclinical hypothyroidism and vascular risk. Journal of Clinical Endocrinology & Metabolism, 93(8), 2795–2801.
• Scragg, R., et al. (2018). Vitamin D supplementation and cardiovascular disease. JAMA Cardiology, 2(3), 1–10.
• Zimmermann, M. B. (2011). The role of iodine, selenium, and iron in thyroid hormone synthesis. Nature Reviews Endocrinology, 7, 619–629.

SEO tags: thyroid awareness, low T3 syndrome, deiodinase-1, free T3 optimization, hypothyroidism symptoms, integrative chiropractic care, functional medicine thyroid, GLP-1 and thyroid, stress and thyroid conversion, desiccated thyroid therapy, El Paso integrative clinic, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, internal medicine and chiropractic collaboration, reverse T3, thyroid lab interpretation, autonomic balance and thyroid